{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T13:50:09Z","timestamp":1762005009869,"version":"3.37.3"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100011797","name":"Turku University Hospital","doi-asserted-by":"crossref","award":["13856"],"award-info":[{"award-number":["13856"]}],"id":[{"id":"10.13039\/501100011797","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100002341","name":"Academy of Finland","doi-asserted-by":"crossref","award":["258814"],"award-info":[{"award-number":["258814"]}],"id":[{"id":"10.13039\/501100002341","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Turku University Foundation","award":["NA"],"award-info":[{"award-number":["NA"]}]},{"name":"the Finnish MS Foundation","award":["NA"],"award-info":[{"award-number":["NA"]}]},{"DOI":"10.13039\/501100004012","name":"Jane ja Aatos Erkon S\u00e4\u00e4ti\u00f6","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004012","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neuroinflammation"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12974-018-1152-2","type":"journal-article","created":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T11:07:18Z","timestamp":1525172838000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Vascular adhesion protein-1 is actively involved in the development of inflammatory lesions in rat models of multiple sclerosis"],"prefix":"10.1186","volume":"15","author":[{"given":"Petri","family":"Elo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sina","family":"Tadayon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heidi","family":"Liljenb\u00e4ck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jarmo","family":"Teuho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meeri","family":"K\u00e4kel\u00e4","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kalle","family":"Koskensalo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Virva","family":"Saunavaara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jenni","family":"Virta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tibor Z.","family":"Veres","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aida","family":"Kiviniemi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antti","family":"Saraste","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P\u00e4ivi","family":"Marjam\u00e4ki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Airas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sirpa","family":"Jalkanen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4006-7977","authenticated-orcid":false,"given":"Anne","family":"Roivainen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,5,1]]},"reference":[{"key":"1152_CR1","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.tins.2010.01.002","volume":"33","author":"V Siffrin","year":"2010","unstructured":"Siffrin V, Vogt J, Radbruch H, Nitsch R, Zipp F. Multiple sclerosis\u2014candidate mechanisms underlying CNS atrophy. Trends Neuros. 2010;33:202\u201310.","journal-title":"Trends Neuros"},{"key":"1152_CR2","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.jneuroim.2006.05.014","volume":"177","author":"L Airas","year":"2006","unstructured":"Airas L, Mikkola J, Vainio JM, Elovaara I, Smith DJ. Elevated serum soluble vascular adhesion protein (VAP-1). J Neuroimmunol. 2006;177:132\u20135.","journal-title":"J Neuroimmunol"},{"key":"1152_CR3","doi-asserted-by":"publisher","first-page":"305","DOI":"10.2967\/jnumed.114.149955","volume":"56","author":"L Airas","year":"2015","unstructured":"Airas L, Dickens AM, Elo P, Marjam\u00e4ki PM, Johansson J, Eskola O, Jones PA, Trigg W, Solin O, Haaparanta-Solin M, Anthony DC, Rinne J. In vivo positron emission tomography imaging demonstrates diminished microglial activation after fingolimod treatment in an animal model of multiple sclerosis. J Nucl Med. 2015;56:305\u201310.","journal-title":"J Nucl Med"},{"key":"1152_CR4","doi-asserted-by":"crossref","first-page":"2068","DOI":"10.1182\/blood.V84.7.2068.2068","volume":"84","author":"TM Carlos","year":"1994","unstructured":"Carlos TM, Harlan JM. Leukocyte-endothelial adhesion molecules. Blood. 1994;84:2068\u2013101.","journal-title":"Blood"},{"key":"1152_CR5","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1126\/science.1529341","volume":"257","author":"M Salmi","year":"1992","unstructured":"Salmi M, Jalkanen S. A 90-kilodalton endothelial cell molecule mediating lymphocyte binding in humans. Science. 1992;257:1407\u20139.","journal-title":"Science"},{"key":"1152_CR6","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1016\/0167-5699(95)80023-9","volume":"16","author":"JP Girard","year":"1995","unstructured":"Girard JP, Springer TA. High endothelial venules (HEVs): specialized endothelium for lymphocyte migration. Immunol Today. 1995;16:449\u201357.","journal-title":"Immunol Today"},{"key":"1152_CR7","doi-asserted-by":"publisher","first-page":"2255","DOI":"10.1084\/jem.178.6.2255","volume":"178","author":"M Salmi","year":"1993","unstructured":"Salmi M, Kalimo K, Jalkanen S. Induction and function of vascular adhesion protein-1 at sites of inflammation. J Exp Med. 1993;178:2255\u201360.","journal-title":"J Exp Med"},{"key":"1152_CR8","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1159\/000090386","volume":"139","author":"A Madej","year":"2006","unstructured":"Madej A, Reich A, Orda A, Szepietowski JC. Expression of vascular adhesion protein-1 in atopic eczema. Int Arch Allergy Immunol. 2006;139:114\u201321.","journal-title":"Int Arch Allergy Immunol"},{"key":"1152_CR9","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/S0197-0186(98)00045-X","volume":"33","author":"V Castillo","year":"1998","unstructured":"Castillo V, Lizcano JM, Visa J, Unzeta M. Semicarbazide-sensitive amine oxidase (SSAO) from human and bovine cerebrovascular tissues: biochemical and immunohistological characterization. Neurochem Int. 1998;33:415\u201323.","journal-title":"Neurochem Int"},{"key":"1152_CR10","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.4049\/jimmunol.161.3.1549","volume":"161","author":"R Kurkij\u00e4rvi","year":"1998","unstructured":"Kurkij\u00e4rvi R, Adams DH, Leino R, M\u00f6tt\u00f6nen T, Jalkanen S, Salmi M. Circulating form of human vascular adhesion protein-1 (VAP-1): increased serum levels in inflammatory liver diseases. J Immunol. 1998;161:1549\u201357.","journal-title":"J Immunol"},{"key":"1152_CR11","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1007\/s00702-007-0699-3","volume":"114","author":"AM O\u2019Rourke","year":"2007","unstructured":"O\u2019Rourke AM, Wang EY, Salter-Cid L, Huang L, Miller A, Podar E, Gao HF, Jones DS, Linnik MD. Benefit of inhibiting SSAO in relapsing experimental autoimmune encephalomyelitis. J Neural Transm. 2007;114:845\u20139.","journal-title":"J Neural Transm"},{"key":"1152_CR12","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/S1471-4906(01)01870-1","volume":"22","author":"M Salmi","year":"2001","unstructured":"Salmi M, Jalkanen S. VAP-1: an adhesin and an enzyme. Trends Immunol. 2001;22:211\u20136.","journal-title":"Trends Immunol"},{"key":"1152_CR13","first-page":"252","volume":"2011","author":"JI Alvarez","year":"1812","unstructured":"Alvarez JI, Cayrol R, Prat A. Disruption of central nervous system barriers in multiple sclerosis. Biochim Biophys Acta. 1812;2011:252\u201364.","journal-title":"Biochim Biophys Acta"},{"key":"1152_CR14","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1191\/1352458503ms965oa","volume":"9","author":"A Minagar","year":"2003","unstructured":"Minagar A, Alexander JS. Blood-brain barrier disruption in multiple sclerosis. Mult Scler. 2003;9:540\u20139.","journal-title":"Mult Scler"},{"key":"1152_CR15","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1097\/WCO.0b013e32832b4c76","volume":"22","author":"P Van der Valk","year":"2009","unstructured":"Van der Valk P, Amor S. Preactive lesions in multiple sclerosis. Curr Opin Neurol. 2009;22:207\u201313.","journal-title":"Curr Opin Neurol"},{"key":"1152_CR16","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1002\/ana.23634","volume":"72","author":"JW Prineas","year":"2012","unstructured":"Prineas JW, Parratt JDE. Oligodendrocytes and the early multiple sclerosis lesion. Ann Neurol. 2012;72:18\u201331.","journal-title":"Ann Neurol"},{"key":"1152_CR17","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/j.ejrad.2008.02.044","volume":"67","author":"A Rovira","year":"2008","unstructured":"Rovira A, Leon A. 2008. MR in the diagnosis and monitoring of multiple sclerosis: an overview. Eur J Radiol. 2008;67:409\u201314.","journal-title":"Eur J Radiol"},{"key":"1152_CR18","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1002\/nbm.1404","volume":"22","author":"S Serres","year":"2009","unstructured":"Serres S, Anthony DC, Jiang Y, Campbell SJ, Broom KA, Khrapitchev A, Sibson NR. Comparison of MRI signatures in pattern I and II multiple sclerosis models. NMR Biomed. 2009;22:1014\u201324.","journal-title":"NMR Biomed"},{"key":"1152_CR19","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s13311-010-0002-4","volume":"8","author":"A Denic","year":"2011","unstructured":"Denic A, Macura SI, Mishra P, Gamez JD, Rodriguez M, Pirko I. MRI in rodent models of brain disorders. Neurotherapeutics. 2011;8:3\u201318.","journal-title":"Neurotherapeutics"},{"key":"1152_CR20","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.neulet.2009.04.033","volume":"458","author":"T Engelhorn","year":"2009","unstructured":"Engelhorn T, Eyupoglu IY, Schwarz MA, Karolczak M, Bruenner H, Struffert T, Kalender W, Doerfler A. In vivo micro-CT imaging of rat brain glioma: a comparison with 3T MRI and histology. Neurosci Lett. 2009;458:28\u201331.","journal-title":"Neurosci Lett"},{"key":"1152_CR21","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1124\/jpet.107.131672","volume":"324","author":"AM O'Rourke","year":"2008","unstructured":"O'Rourke AM, Wang EY, Miller A, Podar EM, Scheyhing K, Huang L, Kessler C, Gao H, Ton-Nu HT, MacDonald MT, Jones DS, Linnik MD. Anti-inflammatory effects of LJP 1586 [Z-3-fluoro-2-(4-methoxybenzyl) allylamine hydrochloride], an amine-based inhibitor of semicarbazide-sensitive amine oxidase activity. J Pharmacol Exp Ther. 2008;324:867\u201375.","journal-title":"J Pharmacol Exp Ther"},{"key":"1152_CR22","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1016\/0306-4522(94)00448-E","volume":"64","author":"MK Matyszak","year":"1995","unstructured":"Matyszak MK, Perry VH. Demyelination in the central nervous system following a delayed-type hypersensitivity response to bacillus Calmette-Gu\u00e9rin. Neuroscience. 1995;64:967\u201377.","journal-title":"Neuroscience"},{"key":"1152_CR23","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/s13550-014-0045-3","volume":"4","author":"H Ahtinen","year":"2014","unstructured":"Ahtinen H, Kulkova J, Lindholm L, Eerola E, Hakanen AJ, Mortiz N, S\u00f6derstr\u00f6m M, Saanijoki T, Jalkanen S, Roivainen A, Aro HT. 68Ga-DOTA-Siglec-9 PET\/CT imaging of peri-implant tissue responses and staphylococcal infections. EJNMMI Res. 2014;4:45.","journal-title":"EJNMMI Res"},{"key":"1152_CR24","doi-asserted-by":"publisher","first-page":"3725","DOI":"10.1182\/blood-2010-09-311076","volume":"118","author":"K Aalto","year":"2011","unstructured":"Aalto K, Autio A, Kiss EA, Elima K, Nymalm Y, Veres TZ, Maksimow M, Marttila-Ichihara F, Elovaara H, Saanijoki T, Crocker PR, Maksimow M, Bligt E, Salminen TA, Salmi M, Roivainen A, Jalkanen S. Siglec-9 is a novel leukocyte ligand for vascular adhesion protein-1 and can be used in PET imaging of inflammation and cancer. Blood. 2011;118:3725\u201333.","journal-title":"Blood"},{"key":"1152_CR25","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1093\/ajcp\/88.5.589","volume":"88","author":"LM Muramoto","year":"1987","unstructured":"Muramoto LM, Kadin ME. Improved detection of lymphoid cell surface antigens in tissues fixed in periodate-lysine-paraformaldehyde (PLP). Am J Pathol. 1987;88:589\u201395.","journal-title":"Am J Pathol"},{"key":"1152_CR26","doi-asserted-by":"publisher","first-page":"5385","DOI":"10.1182\/blood-2009-04-219253","volume":"114","author":"E Kivi","year":"2009","unstructured":"Kivi E, Elima K, Aalto K, Nymalm Y, Auvinen K, Koivunen E, Otto DM, Crocker PR, Salminen TA, Salmi M, Jalkanen S. Human Siglec-10 can bind to vascular adhesion protein-1 and serves as its substrate. Blood. 2009;114:5385\u201392.","journal-title":"Blood"},{"key":"1152_CR27","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1111\/j.1365-2990.2007.00911.x","volume":"34","author":"L Airas","year":"2008","unstructured":"Airas L, Lindsberg PJ, Karjalainen-Lindsberg ML, Mononen I, Kotisaari K, Smith DJ, Jalkanen S. Vascular adhesion protein-1 in human ischaemic stroke. Neuropathol Appl Neurobiol. 2008;34:394\u2013402.","journal-title":"Neuropathol Appl Neurobiol"},{"key":"1152_CR28","doi-asserted-by":"crossref","first-page":"4459","DOI":"10.1182\/blood.V90.11.4459","volume":"90","author":"B Engelhardt","year":"1997","unstructured":"Engelhardt B, Vestweber D, Hallmann R, Schultz M. E-and P-selectin are not involved in the recruitment of inflammatory cells across the blood-brain barrier in experimental autoimmune encephalomyelitis. Blood. 1997;90:4459\u201372.","journal-title":"Blood"},{"key":"1152_CR29","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1002\/eji.1830260415","volume":"26","author":"AM Arvilommi","year":"1996","unstructured":"Arvilommi AM, Salmi M, Kalimo K, Jalkanen S. Lymphocyte binding to vascular endothelium in inflamed skin revisited: a central role for vascular adhesion protein-1 (VAP-1). Eur J Immunol. 1996;26:825\u201333.","journal-title":"Eur J Immunol"},{"key":"1152_CR30","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.immuni.2004.12.006","volume":"22","author":"CM Stolen","year":"2005","unstructured":"Stolen CM, Martilla-Ichihara F, Koskinen K, Yegutkin GG, Turja R, Bono P, Skurnik M, Hanninen A, Jalkanen S, Salmi M. Absence of the endothelial oxidase AOC3 leads to abnormal leukocyte traffic in vivo. Immunity. 2005;22:105\u201315.","journal-title":"Immunity"},{"key":"1152_CR31","doi-asserted-by":"publisher","first-page":"1972","DOI":"10.1093\/brain\/awl135","volume":"129","author":"D Merkler","year":"2006","unstructured":"Merkler D, Ernsting T, Kerschensteiner M, Bruck W, Stadelmann C. A new focal EAE model of cortical demyelination: multiple sclerosis-like lesions with rapid resolution of inflammation and extensive remyelination. Brain. 2006;129:1972\u201383.","journal-title":"Brain"},{"key":"1152_CR32","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1093\/brain\/awp070","volume":"132","author":"JM Frischer","year":"2009","unstructured":"Frischer JM, Bramow S, Dal-Bianco A, Lucchinetti CF, Rauschka H, Schmidbauer H, Laursen H, Sorensen PS, Lassmann H. The relation between inflammation and neurodegeneration in multiple sclerosis brains. Brain. 2009;132:1175\u201389.","journal-title":"Brain"},{"key":"1152_CR33","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1111\/j.1365-2249.1993.tb03377.x","volume":"92","author":"GD Ross","year":"1993","unstructured":"Ross GD, Vetvicka V. CR3 (CD11b, CD18): a phagocyte and NK cell membrane receptor with multiple ligand specificities and functions. Clin Exp Immunol. 1993;92:181\u20134.","journal-title":"Clin Exp Immunol"},{"key":"1152_CR34","doi-asserted-by":"publisher","first-page":"1939","DOI":"10.1002\/1521-4141(200207)32:7<1939::AID-IMMU1939>3.0.CO;2-S","volume":"32","author":"L Svensson","year":"2002","unstructured":"Svensson L, Abdul-Majid KB, Bauer J, Lassmann H, Harris RA, Holmdahl R. A comparative analysis of B cell-mediated myelin oligodendrocyte glycoprotein-experimental autoimmune encephalomyelitis pathogenesis in B cell-deficient mice reveals an effect on demyelination. Eur J Immunol. 2002;32:1939\u201346.","journal-title":"Eur J Immunol"},{"key":"1152_CR35","doi-asserted-by":"publisher","first-page":"1905","DOI":"10.1002\/1521-4141(200207)32:7<1905::AID-IMMU1905>3.0.CO;2-L","volume":"32","author":"JA Lyons","year":"2002","unstructured":"Lyons JA, Ramsbottom MJ, Cross AH. Critical role of antigen-specific antibody in experimental autoimmune encephalomyelitis induced by recombinant myelin oligodendrocyte glycoprotein. Eur J Immunol. 2002;32:1905\u201313.","journal-title":"Eur J Immunol"},{"key":"1152_CR36","doi-asserted-by":"publisher","first-page":"3432","DOI":"10.1002\/(SICI)1521-4141(199911)29:11<3432::AID-IMMU3432>3.0.CO;2-2","volume":"29","author":"JA Lyons","year":"1999","unstructured":"Lyons JA, San M, Happ MP, Cross AH. B cells are critical to induction of experimental allergic encephalomyelitis by protein but not by a short encephalitogenic peptide. Eur J Immunol. 1999;29:3432\u20139.","journal-title":"Eur J Immunol"},{"key":"1152_CR37","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1111\/j.1750-3639.2008.00182.x","volume":"19","author":"CA Foster","year":"2008","unstructured":"Foster CA, Mechtcheriakova D, Storch MK, Balatoni B, Howard LM, Bornancin F, Wlachos A, Sobanov J, Kinnunen A, Baumruker T. FTY720 rescue therapy in the dark agouti rat model of experimental autoimmune encephalomyelitis: expression of central nervous system genes and reversal of blood-brain-barrier damage. Brain Pathol. 2008;19:254\u201366.","journal-title":"Brain Pathol"},{"key":"1152_CR38","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1016\/S0002-9440(10)62300-0","volume":"166","author":"M Merinen","year":"2005","unstructured":"Merinen M, Irjala H, Salmi M, Jaakkola I, H\u00e4nninen A, Jalkanen S. Vascular adhesion protein-1 is involved in both acute and chronic inflammation in the mouse. Am J Pathol. 2005;166:793\u2013800.","journal-title":"Am J Pathol"}],"container-title":["Journal of Neuroinflammation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12974-018-1152-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12974-018-1152-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12974-018-1152-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,6]],"date-time":"2024-07-06T11:59:21Z","timestamp":1720267161000},"score":1,"resource":{"primary":{"URL":"https:\/\/jneuroinflammation.biomedcentral.com\/articles\/10.1186\/s12974-018-1152-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5,1]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["1152"],"URL":"https:\/\/doi.org\/10.1186\/s12974-018-1152-2","relation":{},"ISSN":["1742-2094"],"issn-type":[{"type":"electronic","value":"1742-2094"}],"subject":[],"published":{"date-parts":[[2018,5,1]]},"assertion":[{"value":"4 August 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 April 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 May 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Sirpa Jalkanen is the founder of VAP-1.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Authors\u2019 information"}},{"value":"All study protocols and procedures were reviewed and approved by the national Animal Experiment Board of Finland and the Regional State Administrative Agency for Southern Finland (license number ESAVI\/3046\/04.10.07\/2014) and conducted in accordance with the relevant European Union directive.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Sirpa Jalkanen is a shareholder in Faron Ventures Ltd. Other authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"128"}}